Latest Induced pluripotent stem cell Stories
A research team led by Professor Noriyuki Tsumaki of the Center for iPS Cell Research and Application (CiRA) at Kyoto University and Dr. Hidetatsu Ohtani, a former CiRA member who now works as a post doctoral fellow at Osaka University Graduate School of Medicine, has succeeded in directly converting human dermal fibroblasts into induced chondrogenic cells (iChon cells) without passing through an iPS cell stage in a process known as direct reprogramming.
Researchers have discovered how the most common genetic abnormality in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) kills neurons and have successfully developed a therapeutic strategy to block this neurodegeneration in neurons made from the skin cells of ALS patients.
Researchers have discovered a new, highly efficient way to produce neural stem cells from human pluripotent stem cells that can then go on to form neurons in the brain.
RnRMarketResearch.com adds latest report on “Opportunities in Human Embryonic Stem Cell (hESC) Products – Trends and Forecasts to 2017” to its store. Dallas,
The ability to make induced pluripotent stem cells (iPSCs) from mature cells in the body holds great potential for improved drug screening, disease modeling, and medical treatments for numerous conditions.
Induced pluripotent stem cells (iPSCs) taken from a patient hold great therapeutic potential for many diseases.
Discovery of RNA regulator could lead to a better understanding of diseases like cancer and influenzaSingapore, Sept 9, 2013 - (ACN Newswire) - Scientists at A*STAR's
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.